Cargando…
Comparative genomics allowed the identification of drug targets against human fungal pathogens
BACKGROUND: The prevalence of invasive fungal infections (IFIs) has increased steadily worldwide in the last few decades. Particularly, there has been a global rise in the number of infections among immunosuppressed people. These patients present severe clinical forms of the infections, which are co...
Autores principales: | Abadio, Ana Karina R, Kioshima, Erika S, Teixeira, Marcus M, Martins, Natalia F, Maigret, Bernard, Felipe, Maria Sueli S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042012/ https://www.ncbi.nlm.nih.gov/pubmed/21272313 http://dx.doi.org/10.1186/1471-2164-12-75 |
Ejemplares similares
-
Identification of New Antifungal Compounds Targeting Thioredoxin Reductase of Paracoccidioides Genus
por: Abadio, Ana Karina Rodrigues, et al.
Publicado: (2015) -
Crystal structure of thioredoxin 1 from Cryptococcus neoformans at 1.8 Å resolution shows unexpected plasticity of the loop preceding the catalytic site
por: Bravo-Chaucanés, Claudia Patricia, et al.
Publicado: (2020) -
One Century of Study: What We Learned about Paracoccidioides and How This Pathogen Contributed to Advances in Antifungal Therapy
por: Seki Kioshima, Erika, et al.
Publicado: (2021) -
Two New 1,3,4-Oxadiazoles With Effective Antifungal Activity Against Candida albicans
por: Capoci, Isis Regina Grenier, et al.
Publicado: (2019) -
Antifungal activity of two oxadiazole compounds for the paracoccidioidomycosis treatment
por: Rodrigues-Vendramini, Franciele Abigail Vilugron, et al.
Publicado: (2019)